Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases.
Rights May 13, 2020 May 14, 2020 Apr 30, 2020 Rights ratio: 1 share for every 15 held at a price of Rs 1257.0 Rights May 13, 2020 May 14, 2020 Apr 30, 2020 Rights ratio: 1 share for every 15 held at a ...
Bonus Jun 30, 2022 Jul 01, 2022 May 17, 2022 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Mar 15, 2018 Mar 17, 2018 Jan 30, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 18, ...